PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH COMBINATIONS OF PROSTAGLANDIN ANALOGUES AND BETA-BLOCKERS

PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH COMBINATIONS OF PROSTAGLANDIN ANALOGUES AND BETA-BLOCKERS

pharmacoeconomic study of treatment primary open-angle glaucoma with combinations of prostaglandin analogues and beta-blockers by mean of cost-efficacy and budget impact analysis. Results have shown, that Duotrav (travoprost+timolol) has benefits compare with Xalacom (latanoprost+timolol) from cost-...

Full description

Bibliographic Details
Main Authors:	A. Yu. Kulikov, V. G. Serpikov
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2015-03-01
Series:	Фармакоэкономика
Subjects:	primary open-angle glaucoma pharmacoeconomic studies cost-efficacy analysis budget impact analysis duotrav xalacom travoprost latanoprost timolol
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/31

Similar Items

Short-term efficacy analysis of domestic and imported prostaglandins on treating open angle glaucoma
by: Zhen-Chao Chen, et al.
Published: (2016-02-01)

Long-Term Effectiveness and Safety of Tafluprost, Travoprost, and Latanoprost in Korean Patients with Primary Open-Angle Glaucoma or Normal-Tension Glaucoma: A Multicenter Retrospective Cohort Study (LOTUS Study)
by: Joon-Mo Kim, et al.
Published: (2021-06-01)

Intraocular pressure-lowering effects of commonly used fixed combination drugs with timolol in the management of primary open angle glaucoma
by: Murat Atabey Ozer, et al.
Published: (2014-10-01)

Meta-analysis of efficacy between Travoprost and Timolol in treating primary open angle glaucoma
by: Wan-Jing Xu, et al.
Published: (2022-04-01)

Effect of latanoprost combined with timolol treatment on visual function, intraocular pressure and ocular blood flow of open angle glaucoma
by: Yan-Xia Zhao
Published: (2015-01-01)

Comparison of the efficacy and safety of fixed combination travoprost/timolol and dorzolamide/timolol in patients with primary open-angle glaucoma and ocular hypertension
by: Babić Nikola, et al.
Published: (2013-01-01)

Comparison of the Efficacy of Latanoprost, Bimatoprost, and Travoprost in Patients with Primary Open-Angle Glaucoma and Ocular Hypertension
by: Nur Çolak, et al.
Published: (2014-05-01)

Effect of Topical Prostaglandin Analogue Therapy on Central Corneal Thickness: A Systematic Review
by: Jae-Yun Kim, et al.
Published: (2022-12-01)

PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS
by: M. V. Protsenko
Published: (2015-03-01)

Efficacy and safety of Latanoprost/Timolol fixed combinations in treatment of refractory glaucoma following vitrectomy in short period
by: Ting Wang, et al.
Published: (2013-09-01)

PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH CARBONIC ANHYDRASE INHIBITORS
by: A. Yu. Kulikov, et al.
Published: (2015-03-01)

Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma
by: Yulong Wang, et al.
Published: (2020-11-01)

Efficacy and safety of latanoprost/timolol fixed combination dosed twice daily compared to once daily in patients with primary open angle glaucoma
by: Anis Baidura Azal, et al.
Published: (2023-08-01)

Long-term assessment of prostaglandin analogs and timolol fixed combinations vs prostaglandin analogs monotherapy
by: Ai-Wei Liu, et al.
Published: (2016-05-01)

EFFICACY OF TRAVOPROST IN THE MANAGEMENT OF GLAUCOMA IN DOGS
by: H. Shanthala, et al.
Published: (2018-07-01)

Prostaglandin analogs in ophthalmology
by: S Subbulakshmi, et al.
Published: (2023-01-01)

Effect of latanoprost on open angle glaucoma
by: Min Zhang, et al.
Published: (2018-06-01)

Improved Efficacy of Topical Latanoprost 0.005% Demonstrated by Corneal Biomechanical Correcting Modified Goldmann Prism
by: Radcliffe N, et al.
Published: (2020-08-01)

Fixed combination of latanoprost and timolol vs the individual components for primary open angle glaucoma and ocular hypertension:a systematic review and meta-analysis
by: Yi Xing, et al.
Published: (2014-10-01)

Efficacy and safety of latanoprost versus timolol for primary open angle glaucoma and ocular hypertension: a Meta-analysis
by: Yang-Yang Wu, et al.
Published: (2014-03-01)

Efficacy of Monotherapy with Either Bimatoprost or Travoprost in Patients with Primary Open-Angle Glaucoma Resistant to Latanoprost Therapy
by: Yusuf Koçluk, et al.
Published: (2011-10-01)

Determination of five prostaglandin analogs in eyelash enhancing cosmetics by LC-MS/MS
by: XU Yong, et al.
Published: (2022-02-01)

Efficacy And Safety Of Travoprost Versus Timolol To Treat Early-Onset Ocular Hypertension Secondary To Vitrectomy: A Randomized Trial
by: Fang Y, et al.
Published: (2019-09-01)

A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension
by: Tao Wang, et al.
Published: (2022-11-01)

Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease
by: Sang-Woo Park, et al.
Published: (2022-02-01)

Effects of drug combination on optic disc parameters and retinal nerve fiber layer thickness of high intraocular pressure type POAG patients
by: Ming-Li Ji, et al.
Published: (2017-12-01)

Effects of Latanoprost 0.005%/Timolol Maleate 0.5% and Dorzolamide 2%/Timolol Maleate 0.5% Fixed Combinations on 24-hour Intraocular Pressure in Patients with Primary Open-Angle Glaucoma
by: Berna Yüce, et al.
Published: (2012-01-01)

Comparative study of brimonidine and timolol in treatment of glaucoma
by: Jagadish Chandrarao Narasaiah Lakkineni
Published: (2015-01-01)

Efficacy and safety of carteolol long-acting solution 2% compared with timolol gel-forming solution 0.5% in patients with primary open-angle glaucoma and ocular hypertension: A randomized, parallel-group, open-label phase IV study in Taiwan
by: Hsin-Yu Yao, et al.
Published: (2014-01-01)

PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER
by: R. I. Yagudina, et al.
Published: (2015-03-01)

Comparing the efficacy of Xalatan and a similar latanoprost(Drenatan)in open angle glaucoma patients
by: Bernardo de Pádua Soares Bezerra, et al.
Published: (2017-10-01)

Comparison of clinical effects of two latanoprost 0.005% solutions (Xalatan® and Arulatan®) in primary open-angle glaucoma or ocular hypertensive patients: a randomized clinical trial
by: Brant Fernandes RA, et al.
Published: (2019-04-01)

RETRACTED: Opportunities of the method «Budget impact analysis» for performing pharmacoeconomic research
by: V. V. Ryazhenov, et al.
Published: (2022-06-01)

High Performance Liquid Chromatography Tandem Mass Spectrometry Measurement of Bimatoprost, Latanoprost and Travoprost in Eyelash Enhancing Cosmetic Serums
by: Emilia Marchei, et al.
Published: (2016-02-01)

Pharmacoeconomic analysis in various nosologies
by: A. A. Svistunov, et al.
Published: (2022-12-01)

Prospective, non-interventional, multicenter study of the intraocular pressure-lowering effects of prostaglandin analog/prostamide-containing therapies in previously treated patients with open-angle glaucoma or ocular hypertension
by: Tamçelik N, et al.
Published: (2017-04-01)

THE FEATURES OF METHODOLOGY FOR PHARMACOECONOMICS ANALYSIS OF VACCINATION
by: A. Yu. Kulikov, et al.
Published: (2015-03-01)

Pharmacoeconomic analysis of Anti-inhibitor coagulant complex (AICC) in the treatment of inhibitor hemophilia
by: R. I. Yagudina, et al.
Published: (2015-03-01)

Pharmacoeconomic analysis of fluid therapy in the treatment of patients with peritonitis
by: R. I. Yagudina, et al.
Published: (2015-03-01)

Eficácia do travoprosta 0,004% na redução da pressão intraocular em pacientes com glaucoma
by: Juliana Almodin, et al.